lars bullinger | eha 2018 | what are the clinical implications of mutations in aml?
Published 6 years ago • 299 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
3:55
what aml mutations are associated with adverse outcomes?
-
20:33
from mds to aml: genetics of progression (featuring prof lars bullinger)
-
20:33
from mds to aml: genetics of progression (featuring prof lars bullinger)
-
37:52
what results are needed prior to therapy initiation in newly diagnosed aml?
-
2:36
what is acute myeloid leukemia (aml)? #aml
-
47:56
aml diagnosis and treatment 2022
-
1:51
novel insights into genomic classification and prognosis in aml
-
2:46
know aml | acute myeloid leukemia signs and symptoms
-
2:32
how quickly does aml progress? #aml
-
9:38
pathology-acute myeloid leukemia | aml made easy | clinical features and diagnosis #acuteleukemias
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
5:53
therapeutic approaches based on mutations in aml
-
1:54
what are the lab abnormalities you will usually see in newly diagnosed aml? #aml
-
1:52
how do genomic and epigenomic alterations synergize in aml?
-
5:27
factors to consider when choosing an aml treatment
-
2:58
what are big data, and can they help to better classify aml subtypes?
-
1:45
getitd for flt3-itd-based mrd monitoring in aml
-
1:22
pre-leukemic stem cells: a telltale sign of aml
-
1:01:13
acute myeloid leukemia: what to know, what to do
-
3:55
understanding aml treatment categories
-
2:01
aml: data to look forward to in 2018 and beyond
-
2:56
diagnosis & treatment of aml